Yushi Feng

Yushi Feng has extensive work experience in the pharmaceutical and biotechnology industry. They most recently served as the Vice President at Capricor Therapeutics, Inc. starting in 2023. Prior to that, Yushi was the Vice President and Head of Regulatory Affairs at Codiak BioSciences from 2022 to 2023. Yushi also held the role of Senior Director and Regulatory Specialist at Codiak BioSciences from 2020 to 2022. Before joining Codiak BioSciences, Yushi worked as the Director of Regulatory Affairs at Wave Life Sciences from 2019 to 2020. Yushi gained valuable regulatory experience at the FDA, where they served as CMC Product Quality Reviewer and Application Technical Lead for NDA's from 2015 to 2019. Yushi started their career at Eli Lilly and Company as a Senior Research Scientist from 2011 to 2015 and as a Research Scientist from 2008 to 2011. Prior to that, Yushi worked at Vertex Pharmaceuticals as a Scientist II and Scientist I from 2006 to 2007. Yushi also had summer internships at Pharmacia and Pfizer in 2002 and 2001, respectively.

Yushi Feng completed a doctoral degree in Pharmaceutics from the University of Minnesota, beginning in 2000 and completing it in 2006. Prior to this, it is known that Yushi Feng attended the Ocean University of China, however, specific information regarding degree or field of study is unavailable.